FGFR2-inhibitor (cogent bioscience)

N/A

Report date: 2023/11/20 17:34:37
NME

Base Information

Drug NameFGFR2-inhibitor (cogent bioscience)
Drug Alias NameFGFR2-inhibitorCGT-3103CGT3103
ClassificationSmall molecules
Mechanisms of ActionFibroblast growth factor receptor 2 inhibitors
TargetsFibroblast growth factor receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCogent Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCogent Biosciences Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A